Clinical trials of radiosensitizers: What should we expect?
- 31 March 1984
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (3) , 425-429
- https://doi.org/10.1016/0360-3016(84)90063-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Selection of appropriate studies for phase III trials of radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Survival measurements at low doses: oxygen enhancement ratioBritish Journal of Cancer, 1982
- A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivoBritish Journal of Cancer, 1982
- Radiosensitization of Hypoxic Tumor Cells by Depletion of Intracellular GlutathioneScience, 1982
- Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agentsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical useInternational Journal of Radiation Oncology*Biology*Physics, 1981
- A serial study of the concentration of misonidazole in human tumors correlated with histologic structureInternational Journal of Radiation Oncology*Biology*Physics, 1981
- The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizersThe British Journal of Radiology, 1980
- Interaction of misonidazole and oxygen in the radiosensitization of mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian CellsRadiation Research, 1976